Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Healthy Volunteers
Interventions
BIOLOGICAL

Modified Vaccinia Ankara

Healthy volunteers will receive intramuscularly 1 injection of MVA-CMDR 1ml (Total 10 power 8 pfu) boost injection in the left deltoid muscle.

Trial Locations (1)

Unknown

Muhimbili University of Health and Allied Sciences, Dar es Salaam

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Swedish Institute for Infectious Disease Control

OTHER

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

lead

Muhimbili University of Health and Allied Sciences

OTHER

NCT01461447 - Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines | Biotech Hunter | Biotech Hunter